Seite drucken
Publikationen  / 2006

Publikationen 2006


Melms A, Luther C, Stoeckle C, Pöschel S, Schroth P, Varga M, Wienhold W, Tolosa E.  Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells. Acta Neurol Scand Suppl. 2006;183:12-13. PubMed

Amend B, Doster H, Lange C, Dubois E, Kalbacher H, Melms A, Bischof F.  Induction of autoimmunity by expansion of autoreactive CD4+CD62low cells in vivo. J Immunol. 2006;177:4384-4390. PubMed

Ruckrich T, Brandenburg J, Cansier A, Muller M, Stevanovic S, Schilling K, Wiederanders B, Beck A, Melms A, Reich M, Driessen C, Kalbacher H. Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain. Biol Chem. 2006;387:1503-1511. PubMed

Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A*, Salih HR*. Soluble MICA in malignant diseases. Int J  Cancer. 2006;118:684-687. * equal contribution. PubMed

Schreiner B, Voss J, Wischhusen J, Dombrowski Y, Steinle A, Lochmüller H, Dalakas M, Melms A, Wiendl H. The role of toll-like receptors in human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myophaties, mediates IL-8 release and upregulation of NKG2D-ligands. FASEB J. 2006; 20:118-120. PubMed

Busche A, Goldmann T, Naumann U, Steinle A, Brandau S. NK-mediated rejection of experimental human lung cancer by genetic overexpression of MICA. Hum Gene Ther. 2006;17:135-146. PubMed

Salih HR, Goehlsdorf D, Steinle A. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients. Hum Immunol. 2006;67(3):186-195. PubMed

Waldhauer I, Steinle A. Proteolytic release of soluble UL16-binding protein 2 (ULBP2) from tumor cells. Cancer Res. 66(5):2520-6. PubMed

Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela J-M, Rousselot P, Tamouza R, Lebouteiller P, Mahon FX, Steinle A, Charron D, Dombret H, Toubert A. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J Immunol. 176(8):5108-16. PubMed

Pereira PL, Boss A, Clasen S, Gouttefangeas C, Schmidt S, Claussen CD. Percutaneous radiofrequency ablation: Technologies, current aspects, and optimized techniques. Recent Results Cancer Res. 2006;167:39-52. PubMed

Pawelec G, Koch S, Griesemann H, Rehbein A, Hahnel K, Gouttefangeas C. Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother. 2006;55:981-986. PubMed

Dürr M, Kristian SA, Otto M, Matteoli G, Margolis PS, Trias J, Van Kessel KP, Van Strijp JA, Bohn E, Landmann R, Peschel A. Neutrophil chemotaxis by pathogen-associated molecular patterns - formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol. 2006;8:207-217. PubMed

Peschel A, Sahl HG. The coevolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol. 2006;4:529-36. PubMed

Spreu J, Stehle T, Steinle A. Human Cytomegalovirus-encoded UL16 discriminates MIC molecules by their alpha-2 domains.  J Immunol. 2006;177:3143-3149. PubMed

Welte S, Kuttruff S, Waldhauer I, Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol. 2006;7:1334-1342.PubMed

Biedermann T*, Lametschwandtner G, Tangemann K, Kund J, Hinteregger S, Carballido-Perrig N, Rot A, Schwärzler C, Carballido JM*. IL-12 instructs skin homing of human Th2 cells. J Immunol. 177:3763-3770; 2006. * Corresponding authors.  PubMed

Keine News in dieser Ansicht.

   Werbeagentur: |